Ò½ÉúµÇ¼
ÆóÒµ/Ò©³§µÇ¼
ÇëÊäÈëÄúµÄÒ½ÉúÕ˺ŵǼ
Óû§Ãû£º
ÃÜ  Â룺
 ¼ÇסÃÜÂë    
 ×¢²á»áÔ±     ÕÒ»ØÃÜÂë
ÇëÊäÈëÄúµÄÆóÒµ/Ò©³§Õ˺ŵǼ
Óû§Ãû£º
ÃÜ  Â룺
 ¼ÇסÃÜÂë    
 ×¢²á»áÔ±     ÕÒ»ØÃÜÂë
¸÷´óÖÞ¹ú¼Ò£º
»áÕ¹¿ÆÊÒ£º
»áչʱ¼ä£º
¹Ø¼ü×ÖËÑË÷£º
北美洲
Äúµ±Ç°µÄλÖÃ:Ê×Ò³ > Õ¹»á¼Æ»® > 北美洲
2011Äê2011Äê¹ú¼ÊTϸ°ûÁÜ°ÍÁöÂÛ̳£¨TLF£©

»áÕ¹Ãû³Æ  2011Äê¹ú¼ÊTϸ°ûÁÜ°ÍÁöÂÛ̳£¨TLF£©
²¼Õ¹Ê±¼ä  2011Äê1ÔÂ26ÈÕ
Õ¹ÀÀʱ¼ä  2011Äê1ÔÂ27ÈÕ—2011Äê1ÔÂ29ÈÕ
³·Õ¹Ê±¼ä  2011Äê1ÔÂ30ÈÕ
»áÕ¹³¡¹Ý

 ¾É½ðɽ

Ö÷°ìµ¥Î»  
³Ð°ìµ¥Î»  
Э°ìµ¥Î»   
»áÕ¹Àà±ð  
ËùÔÚµØÇø

 ÃÀ¹ú ¾É½ðɽ

»áÕ¹ÃèÊö

 This forum will provide a platform for discussion about the classification, epidemiology, prognosis, and pathogenesis of several T-cell lymphoma subtypes. In addition, the latest information on novel agents and treatment approaches will be presented by T-cell lymphoma experts. This meeting is intended for hematologists, oncologists, and other clinicians and scientists with an interest in T-cell lymphoma.
 
 ±¾´ÎÂÛ̳½«Ìṩһ¸öÓйصķÖÀ࣬Á÷Ðв¡Ñ§£¬Ô¤ºó£¬ºÍ¼¸¸öTϸ°ûÁÜ°ÍÁöÑÇÐ͵ķ¢²¡»úÖƵÄÌÖÂÛƽ̨¡£´ËÍ⣬ÔÚÐÂÐÍÒ©ÎïºÍÖÎÁÆ·½·¨µÄ×îÐÂÐÅÏ¢½«Ìá½»µÄT-ϸ°ûÁÜ°ÍÁöµÄר¼Ò¡£
Õâ´Î»áÒéÊÇΪѪҺ¿Æ£¬Ö×Áö¿ÆҽʦÓëÆäËûҽʦ£¬²¢ÓëÔÚTϸ°ûÁÜ°ÍÁöÐËȤµÄ¿Æѧ¼Ò

²ÎÕ¹·ÑÓÃ

¡¡

¹ã¸æ·ÑÓÃ

¡¡

Õ¹»áÖÜÆÚ

 Ã¿ÄêÒ»½ì

Õ¹»á¹æÄ£

¡¡

×¢ÒâÊÂÏî

 

ÁªÏµ·½Ê½

 ×Éѯµç»°: 8610-66054455  8610-51294800   
 ÔÚÏß¿Í·þ: MSN:fanmeiguojikefu@hotmail.com    QQ:1391456367

ÓÑÇéÁ´½Ó£º 
| ÁªÏµµç»°£º010-66054488 | ÔÚÏß¿Í·þ£ºQQ 1391456367 | µØÖ·£º±±¾©Êж«³ÇÇø½ðÓã³ØÖнÖ2ºÅÔº4-2-506 |
°æȨËùÓÐ È«Çòҽѧ»áÕ¹ All rights Reserved. ICPÖ¤£º¾©ICP±¸10011105ºÅ-2